Protea to Develop Albumin-capture Tool Based on Johns Hopkins Research

Jenny Van Eyk and others at JHU have discovered that during myocardial ischemia, the albumin molecule can change, which may prove clinically relevant. Protea plans to apply the findings to develop products to analyze albumin from the bloodstream.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories